The largest shareholder in Clanoech AB is Rosetta Capital IV S.à r.l. Rosetta Capital is a specialist venture capital firm focused in the life science and medical technology sectors. Rosetta is headquartered in the United Kingdom and manages funds comprising more than 30 active portfolio companies across Europe, North America and Asia.
The second largest shareholder is founder Yihai Cao, MD PhD, Professor at the Microbiology and Tumor Biology Center at Karolinska Institutet, Sweden, specialized in regulation of angiogenesis.
ClanoTech AB • Fogdevreten 2 • S-17165 Solna • Sweden • Org. nr. 556706-6658 • Registered office: Solna